Skip to content
JAMA Neurology Author Interviews cover art

All episodes

JAMA Neurology Author Interviews, 130 episodes. Page 1 of 2.

#
Title
1

Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk

2

Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease

3

Gefurulimab and Generalized Myasthenia Gravis

4

Acoustic Analysis of Primary Care Patient–Clinician Conversations to Screen for Cognitive Impairment

5

Phenoconversion in Pure Autonomic Failure

6

Brain Biomarkers and a Multidomain Lifestyle Intervention

7

Epstein-Barr Virus Antibodies and Multiple Sclerosis

8

Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy

9

US Burden of Disorders Affecting the Nervous System

10

Hemorrhage and Risk Factors in Unruptured Brain AVM

11

Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

12

GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension

13

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

14

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

15

Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke

16

Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage

17

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine

18

β-Blocker Use and Delayed Onset and Progression of Huntington Disease

19

Alzheimer Disease as a Clinical-Biological Construct

20

Perceived CTE in Former Professional Football Players

21

Localized Nicardipine Release Implants for Prevention of Vasospasm

22

Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events

23

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

24

Association of New-Onset Seizures With SARS-CoV-2 Vaccines

25

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

26

Posttraumatic Epilepsy and Dementia Risk

27

Risk of Stroke and Myocardial Infarction Among Initiators of Triptans

28

Risk Factors for Young-Onset Dementia in the UK Biobank

29

Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large Infarct

30

Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

31

Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease

32

Neuropathologic and Clinical Findings in Athletes With Repetitive Head Impacts

33

Dementia Risk and Disadvantaged Neighborhoods

34

Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence

35

Risk of Parkinson Disease Among Camp Lejeune Veterans

36

Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders

37

Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

38

Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke

39

Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known Well

40

Autoimmune Encephalitis Misdiagnosis in Adults

41

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

42

Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy

43

Association of Neurocritical Care With Outcomes for Adults With Brain Injury

44

Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo

45

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief

46

Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the US

47

Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

48

Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19

49

Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury

50

Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy

51

Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

52

Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy Bodies

53

Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up

54

Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis

55

Risk of Rupture After Intracranial Aneurysm Growth

56

Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage

57

Tau PET as a Prognostic Marker

58

Association of Nitrogen Dioxide and Other Air Pollution Exposures With the Risk of Parkinson Disease

59

Effect of High-Frequency (10 kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

60

Reperfusion Treatment and Stroke Outcomes in Hospitals with Telestroke Capacity

61

Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era

62

Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor

63

Prehospital Prediction of Large Anterior Vessel Occlusion

64

ED and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders

65

Optic Neuritis Incidence and Prevalence and Association With Systemic and Neurologic Disease

66

Intensive Systolic Blood Pressure Reduction in Intracerebral Hemorrhage

67

Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness

68

Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

69

Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping

70

Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks in Rural and Urban Medicare Patients

71

Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals in the A4 Study Screening Cohort

72

Clinical Effects of Zilucoplan in Patients With Generalized Myasthenia Gravis

73

Associations of APOE ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players

74

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

75

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

76

Interrater Reliability of Experts in Identifying Interictal Epileptiform Discharges in EEGs

77

Rate and Prognosis of Brain Ischemia in Lower-Risk Transient or Persistent Minor Neurologic Events

78

Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction

79

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

80

Efficacy of Home-Based Telerehabilitation In-Clinic Therapy After Stroke

81

Association Between Statin Use and Risk of Dementia After a Concussion

82

Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone

83

Morbidity and Outcomes of Subdural Grids vs Stereoelectroencephalography in Intractable Epilepsy

84

Associations Between Migraine and Type 2 Diabetes in Women—Findings From the E3N Cohort Study

85

Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43

86

Effect of Dextroamphetamine on Poststroke Motor Recovery

87

Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline

88

Association of Sickle Cell Trait With Ischemic Stroke Among African Americans

89

An Epidemiological Timeline of When α-Synucleinopathies Start

90

Maternal Folic Acid Supplementation and Risk of Autistic Traits Following Exposure to Antiepileptic Drugs

91

FUS Thalamotomy for Medication-Refractory, Tremor-Dominant PD

92

Apolipoprotein E and Sex Risk Factors for Alzheimer Disease

93

Cirrhosis and Stroke in a Nationally Representative Cohort

94

Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults

95

Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

96

Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

97

Human Prion Disease Diagnosis Using RT-QuIC Testing

98

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy (JAMA Neurology)

99

Association of TBI and Late-Life Neurodegenerative Conditions

100

Zika Virus as an Emerging Global Pathogen